Cambridge Investment Research Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Buy |
10,842
+320
| +3% | +$4.1K | ﹤0.01% | 3429 |
|
|
2025
Q1 | $134K | Buy |
+10,522
| New | +$134K | ﹤0.01% | 3301 |
|
|
2024
Q2 | – | Sell |
-10,927
| Closed | -$149K | – | 3375 |
|
|
2024
Q1 | $149K | Buy |
10,927
+501
| +5% | +$6.83K | ﹤0.01% | 3094 |
|
|
2023
Q4 | $140K | Sell |
10,426
-1,066
| -9% | -$14.3K | ﹤0.01% | 2987 |
|
|
2023
Q3 | $143K | Sell |
11,492
-765
| -6% | -$9.52K | ﹤0.01% | 2900 |
|
|
2023
Q2 | $166K | Buy |
12,257
+210
| +2% | +$2.84K | ﹤0.01% | 2924 |
|
|
2023
Q1 | $168K | Buy |
+12,047
| New | +$168K | ﹤0.01% | 2875 |
|
|
2022
Q3 | – | Sell |
-15,278
| Closed | -$217K | – | 3109 |
|
|
2022
Q2 | $217K | Buy |
15,278
+348
| +2% | +$4.94K | ﹤0.01% | 2668 |
|
|
2022
Q1 | $247K | Buy |
14,930
+1,982
| +15% | +$32.8K | ﹤0.01% | 2704 |
|
|
2021
Q4 | $249K | Buy |
12,948
+736
| +6% | +$14.2K | ﹤0.01% | 2697 |
|
|
2021
Q3 | $254K | Buy |
12,212
+404
| +3% | +$8.4K | ﹤0.01% | 2606 |
|
|
2021
Q2 | $253K | Buy |
+11,808
| New | +$253K | ﹤0.01% | 2600 |
|
|
2019
Q4 | – | Sell |
-49,523
| Closed | -$748K | – | 2439 |
|
|
2019
Q3 | $748K | Sell |
49,523
-2,603
| -5% | -$39.3K | 0.01% | 1248 |
|
|
2019
Q2 | $878K | Buy |
52,126
+2,863
| +6% | +$48.2K | 0.01% | 1094 |
|
|
2019
Q1 | $844K | Buy |
49,263
+5,308
| +12% | +$90.9K | 0.01% | 1127 |
|
|
2018
Q4 | $664K | Sell |
43,955
-8,876
| -17% | -$134K | 0.01% | 1164 |
|
|
2018
Q3 | $1.08M | Buy |
52,831
+1,264
| +2% | +$25.8K | 0.01% | 982 |
|
|
2018
Q2 | $969K | Sell |
51,567
-649
| -1% | -$12.2K | 0.01% | 999 |
|
|
2018
Q1 | $1M | Buy |
52,216
+962
| +2% | +$18.5K | 0.01% | 937 |
|
|
2017
Q4 | $1.01M | Buy |
51,254
+8,289
| +19% | +$163K | 0.01% | 906 |
|
|
2017
Q3 | $923K | Buy |
42,965
+1,605
| +4% | +$34.5K | 0.01% | 882 |
|
|
2017
Q2 | $862K | Sell |
41,360
-5,233
| -11% | -$109K | 0.01% | 879 |
|
|
2017
Q1 | $903K | Buy |
46,593
+86
| +0.2% | +$1.67K | 0.02% | 771 |
|
|
2016
Q4 | $790K | Buy |
46,507
+1,627
| +4% | +$27.6K | 0.01% | 794 |
|
|
2016
Q3 | $841K | Sell |
44,880
-951
| -2% | -$17.8K | 0.02% | 766 |
|
|
2016
Q2 | $788K | Buy |
45,831
+8,368
| +22% | +$144K | 0.02% | 727 |
|
|
2016
Q1 | $672K | Buy |
37,463
+6,032
| +19% | +$108K | 0.02% | 748 |
|
|
2015
Q4 | $743K | Buy |
31,431
+1,619
| +5% | +$38.3K | 0.02% | 670 |
|
|
2015
Q3 | $671K | Buy |
+29,812
| New | +$671K | 0.02% | 630 |
|
|
2014
Q4 | – | Sell |
-9,303
| Closed | -$206K | – | 1430 |
|
|
2014
Q3 | $206K | Buy |
+9,303
| New | +$206K | 0.01% | 1288 |
|